Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEPA + Megestrol Acetate vs NEPA + Dexamethasone for T-DXd Induced Nausea
NCT07254416Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of megestrol in chemotherapy-induced nausea and vomiting (CINV), sponsored by Tianjin Medical University Cancer Institute and Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07254416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07254416.